跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目9951-9975 / 12927. (共518頁) << < 394 395 396 397 398 399 400 401 402 403 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2021-02-01	Radio-contrast medium exposure and Dialysis risk in patients with chronic kidney disease and congestive heart failure: A case-only study	International Journal of Cardiology. 2021 Feb 01;324:199-204.
2018-12	Radio-sensitivity of IGFBP3 in oral squamous cell carcinoma cells	Cancer Science. 2018 Dec;109(Suppl. 2):511.
2012-11-13	Radioactive gold nanoparticles and methods of making and using them	US8309135B2/2012-11-13
2013-03-14	Radioactive gold nanoparticles and methods of making and using them	AU2009333387/2013-03-14
2015-04-08	Radioactive gold nanoparticles and methods of making and using them	JP5699088/2015-04-08
2015-06-02	Radioactive gold nanoparticles and methods of making and using them	CA2743315/2015-06-02
2014-11	Radioluminescence characterization of in situ x-ray nanodosimeters: Potential real-time monitors and modulators of external beam radiation therapy	Applied Physics Letters. 2014 Nov;105(20):Article number 203110.
2022-03-14	Radiometal-labeled chitosan microspheres as transarterial radioembolization agents against hepatocellular carcinoma	Gels. 2022 Mar 14;8(3):Article number 180.
2017-07	Radiosurgical target distance from the Root Entry Zone in the treatment of trigeminal neuralgia	Practical Radiation Oncology. 2017 Jul;7(4):221-227.
2019-06-10	Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma	BMC Cancer. 2019 Jun 10;19:Article number 560.
2024-10-09	Rainfall events and daily mortality across 645 global locations: Two stage time series analysis	British Medical Journal. 2024 Oct 09;387:Article number e080944.
2022-01	RamAp is an efflux pump regulator carried by an IncHI2 plasmid	Antimicrobial Agents and Chemotherapy. 2022 Jan 18;66(1):Article number e01152-21.
2020-02	Ramucirumab (RAM) or merestinib (MER) or placebo (PL) plus gemcitabine (GEM) and cisplatin (CIS) as first-line treatment for advanced or metastatic biliary tract cancer (BTC): A randomized, double-blind, phase II study	Journal of Clinical Oncology. 2020 Feb;38(4):Meeting Abstract 477.
2013-11-06	Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma	PLoS ONE. 2013 Nov 6;8(11):Article number e79863.
2006-01	Random walk, sequential analysis and related topics: A festschrift in honor of Yuan-Shih Chow.	Random walk, sequential analysis and related topics: A festschrift in honor of Yuan-Shih Chow.
2013-01	Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma	Alimentary Pharmacology and Therapeutics. 2013 Jan;37(1):62-73.
2019-10	Randomised phase 3 study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC) - Integrate II	Annals of Oncology. 2019 Oct;30(Suppl. 6):137.
2010-09	A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients	British Journal of Cancer. 2010 Sep;103(7):954-960.
2004-02-26	A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated	British Journal of Cancer. 2004 Feb;90(2):359-365.
2007-08	A randomised placebo-controlled trial of a traditional chinese herbal formula in the treatment of primary dysmenorrhoea	PLoS ONE. 2007 Aug;2(8):Article number e719.
2004-03	Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer	British Journal of Surgery. 2004 Mar;91(3):283-287.
2019-03	Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients	American Journal of Clinical Nutrition. 2019 Mar;109(3):606-614.
2014-05	Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):TPS4148.
2007-06	A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan	Lung Cancer. 2007 Jun;56(3):363-369.
2013-06-21	A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma	Annals of Oncology. 2013 Jun 21;24(6):1567-1573.

顯示項目9951-9975 / 12927. (共518頁) << < 394 395 396 397 398 399 400 401 402 403 > >> 每頁顯示[10|25|50]項目